We are live on
!
Find out more
VCM
Vision Capital Management Portfolio holdings
AUM
$792M
1-Year Est. Return
18.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+18.17%
3 Year Est. Return
+56.41%
5 Year Est. Return
+57.55%
10 Year Est. Return
+256.21%
AUM
$381M
AUM Growth
+$21.5M
(+6%)
Cap. Flow
+$35.7M
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
46.93%
Holding
85
New
5
Increased
18
Reduced
50
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$31.1M |
| 2 |
Amgen
AMGN
|
+$2.87M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.33M |
| 5 |
NEWR
New Relic, Inc.
NEWR
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.44M |
| 2 |
Apple
AAPL
|
+$1.31M |
| 3 |
CVS Health
CVS
|
+$710K |
| 4 |
Visa
V
|
+$703K |
| 5 |
Amazon
AMZN
|
+$259K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.97% |
| 2 | Consumer Discretionary | 10.16% |
| 3 | Industrials | 7.59% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Marriott International
MAR
$98.7B
| $5.07M | 1.33% |
36,152
+29
| +0.1% | +$3.85K |
|
27
Costco
COST
$415B
| $4.99M | 1.31% |
18,865
-110
| -0.6% | -$27.4K |
|
28
Zoetis
ZTS
$31.6B
| $4.78M | 1.25% |
42,092
-400
| -0.9% | -$41.9K |
|
|
DFS
29
DELISTED
Discover Financial Services
DFS
| $4.52M | 1.19% |
58,292
-337
| -0.6% | -$26.1K |
|
30
IQVIA
IQV
$34.7B
| $4.47M | 1.17% |
27,804
-24
| -0.1% | -$3.37K |
|
|
31
Amgen
AMGN
$203B
| $4.41M | 1.16% |
23,942
+16,013
| +202% | +$2.87M |
|
|
AMTD
32
DELISTED
TD Ameritrade Holding Corp
AMTD
| $4.36M | 1.14% |
87,264
-70
| -0.1% | -$3.63K |
|
33
C.H. Robinson
CHRW
$22B
| $4.36M | 1.14% |
51,634
-305
| -0.6% | -$25.7K |
|
34
NVR
NVR
$17.2B
| $3.98M | 1.04% |
1,181
-5
| -0.4% | -$16K |
|
35
Nike
NKE
$61.9B
| $3.9M | 1.02% |
46,491
-182
| -0.4% | -$15.3K |
|
36
RTX Corp
RTX
$287B
| $3.36M | 0.88% |
41,030
-192
| -0.5% | -$16.1K |
|
37
U-Haul Holding Co
UHAL
$14B
| $3.36M | 0.88% |
88,800
-10
| -0% | -$381 |
|
38
CarMax
KMX
$8.27B
| $3.19M | 0.84% |
36,733
-32
| -0.1% | -$2.5K |
|
39
Gilead Sciences
GILD
$161B
| $2.95M | 0.77% |
43,697
+41
| +0.1% | +$2.7K |
|
40
Middleby
MIDD
$6.05B
| $2.84M | 0.75% |
20,943
+45
| +0.2% | +$6.05K |
|
41
Cognizant
CTSH
$21.5B
| $2.83M | 0.74% |
44,575
-155
| -0.3% | -$10.2K |
|
42
Johnson & Johnson
JNJ
$635B
| $2.76M | 0.73% |
19,838
-310
| -2% | -$42.9K |
|
43
Electronic Arts
EA
$52.4B
| $2.69M | 0.71% |
26,534
-368
| -1% | -$35.1K |
|
|
44
CVS Health
CVS
$137B
| $2.56M | 0.67% |
46,992
-13,193
| -22% | -$710K |
|
45
HF Sinclair
DINO
$15.9B
| $2.38M | 0.63% |
51,524
-370
| -0.7% | -$16.5K |
|
|
MNDT
46
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.35M | 0.62% |
158,558
-187
| -0.1% | -$2.87K |
|
47
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $2.32M | 0.61% |
21,047
-720
| -3% | -$77.2K |
|
48
TFS Financial
TFSL
$5.1B
| $2.15M | 0.56% |
118,897
-970
| -0.8% | -$16.5K |
|
49
Cisco
CSCO
$450B
| $2.08M | 0.55% |
38,034
-570
| -1% | -$31.5K |
|
50
F5
FFIV
$22.1B
| $1.89M | 0.5% |
13,005
+5,196
| +67% | +$778K |
|
Similar funds
AI
M
PWM
AWG
SC
AVLSA
AT
MTWSIF
Vision Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Vision Capital Management held 85 positions worth $381M, up 6% from $360M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Vision Capital Management deployed $35.7M of net new capital in Q2 2019, opening 5 new positions and adding to 18 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 100 shares worth $318K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Apple, an estimated $1.31M trimmed.
- Vision Capital Management's largest Q2 2019 buy was Berkshire Hathaway Class A: 100 shares worth $318K.
- Vision Capital Management added most to Amgen in Q2 2019, an estimated $2.87M increase.
- Vision Capital Management's biggest Q2 2019 reduction was Apple, cutting an estimated $1.31M.
- Vision Capital Management fully exited Allergan plc in Q2 2019, selling an estimated $2.44M.
- Vision Capital Management's ten largest holdings make up 47% of its $381M portfolio in Q2 2019.
- Vision Capital Management opened 5 new positions and closed 1 in Q2 2019.
- Vision Capital Management's portfolio value rose 6% quarter-over-quarter to $381M.
Based on Vision Capital Management's 13F filing for Q2 2019, filed 29 Jul 2019.